PPCH | Propanc Health Group MakesThe Effort Needed

If you were born after 1960, there’s a 50% chance you’ll get cancer at some point in your life which, to be quite honest, pretty much sucks to hear.  Studies have been coming out for decades about the risks of cancer, but recent articles published by many sources (April 1, 2015 MensHealth we’ll be referring to) and the shift of attitude towards the silent killer has made many investors extremely rich by investing ...

Continue Reading →
0

INO | Inovio Pharmaceuticals Shatters All Of Its Records

INO Stock, NYSE AMEX INO, Inovio Pharmaceuticals Inc.,biotech penny stocksThe NYSE Amex listed penny stock of Inovio Pharmaceuticals, Inc. (INO) exploded today after reporting positive test results on their next-generation HIV vaccine, a 7X increase (7% to 52%). Shares of INO stock set a new 52 week high, 1.57, within minutes of the opening bell before pulling back. With both INO stock and ...

Continue Reading →
0

ONCS Stock Breaking 30 On Record Volume

ONCSShares of our penny stock alert from Jun 25, OncoSec Medical Inc. (OTCQB: ONCS) are breaking past 0.30 on what could be a record volume trading session. ONCS stock price has risen as high as 0.298 so far in today’s trading session ...

Continue Reading →
0

OncoSec (ONCS) Preliminary Data Comes After Record Volume

Monday’s trading activity was more than spectacular with OncoSec Medical Inc. (ONCS) having its highest ever trading session with 8,816,988 shares traded. Had it not been for the dumps occurring on Great Wall Builders Ltd (GWBU) and Independence Energy Corp. (IDNGD) which drew ...

Continue Reading →
0

Penny Stock Pick For Monday: OncoSec Medical (ONCS)

Many of you already caught wind of OncoSec Medical Inc. (OTC: ONCS) when we posted it on the site on Tuesday at just 0.18. Even though ONCS is up 22.65% since, Wall Street analysts at Roth Capital initiated coverage on the stock with a “buy” rating Thursday and a $1.00 price ...

Continue Reading →
0

Hot Penny Stocks: DYAX Sets New 52-Week High Friday

Shares of Nasdaq listed penny stock of Dyax Corp. (DYAX) have gained 17.74% since announcing plans to discontinue Ecallantide phase II trials. A week after that announcement, Needham & Company initiated coverage on DYAX setting a “buy” rating and a $3.50 price target on the makers of KALBITOR®. The coverage was initiated based on the Company’s development pipeline with their four drug ...

Continue Reading →
0

Could New Patent Get OncoSec Medical (ONCS) Over A Dollar?

The penny stock of OncoSec Medical Inc. (OTC: ONCS), a company treating advanced-stage solid tumors, had a rally from mid-December to February 1st gaining 488% . Today, ONCS announced the Commissioner of Patents, Commonwealth of Australia Patent Office, recently granted a new Method of ...

Continue Reading →
0